¼¼°èÀÇ ÀÇ·á±â±â °ËÁ¤ ¹× °ËÁõ ½ÃÀå
Medical Device Validation and Verification
»óǰÄÚµå : 1768153
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 378 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,222,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,666,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ÀÇ·á±â±â °ËÁ¤ ¹× °ËÁõ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 18¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 9¾ï 5,310¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ÀÇ·á±â±â °ËÁ¤ ¹× °ËÁõ ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 10.7%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 18¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ±â°è °Ë»ç´Â CAGR 10.1%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 6¾ï 6,840¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. »ý¹°ÇÐÀû ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 11.6%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 2¾ï 4,620¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 14.0%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ÀÇ·á±â±â °ËÁ¤ ¹× °ËÁõ ½ÃÀåÀº 2024³â¿¡ 2¾ï 4,620¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGR 14.0%·Î 2030³â±îÁö 4¾ï 100¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 7.3%¿Í 8.8%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 8.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ÀÇ·á±â±â °ËÁ¤ ¹× °ËÁõ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

ÀÇ·á±â±â °ËÁ¤ ¹× °ËÁõÀÌ Áß¿äÇÑ ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

ÀÇ·á±â±âÀÇ °ËÁ¤ ¹× °ËÁõÀº ÀÇ·á±â±â°¡ ½ÃÀå¿¡ Ãâ½ÃµÇ±â Àü¿¡ ±ÔÁ¦ ±âÁØÀ» ÃæÁ·Çϰí ÀǵµÇÑ ´ë·Î ÀÛµ¿ÇÏ´ÂÁö È®ÀÎÇÏ´Â Áß¿äÇÑ ÇÁ·Î¼¼½ºÀÔ´Ï´Ù. ¹ë¸®µ¥À̼ÇÀº ½ÇÁ¦ Á¶°Ç¿¡¼­ ±â±â°¡ »ç¿ëÀÚÀÇ ¿ä±¸¸¦ ÃæÁ·ÇÏ´ÂÁö È®ÀÎÇϰí, °ËÁõÀº Á¦Ç°ÀÌ ¼³°è »ç¾çÀ» ÁؼöÇÏ´ÂÁö È®ÀÎÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÇÁ·Î¼¼½º´Â ÀÇ·á±â±â °³¹ß¿¡¼­ ¿ÀÀÛµ¿À» ¹æÁöÇϰí, ȯÀÚÀÇ ¾ÈÀüÀ» º¸ÀåÇϸç, FDA ¹× À¯·´ÀǾàǰû(EMA)°ú °°Àº ±ÔÁ¦ ¿ä°ÇÀ» ÁؼöÇϱâ À§ÇØ ÇʼöÀûÀÔ´Ï´Ù. È¿°úÀûÀÎ °ËÁ¤ ¹× °ËÁõ ÇÁ·Î¼¼½º´Â Á¦Ç° ¸®ÄÝÀ» ÁÙÀ̰í, ȯÀÚ °á°ú¸¦ °³¼±Çϸç, ÀÇ·á±â±â ±â¾÷ÀÇ ¸í¼ºÀ» À¯ÁöÇÏ´Â µ¥ ÇÙ½ÉÀûÀÎ ¿ªÇÒÀ» ÇÕ´Ï´Ù.

¾î¶² Çõ½ÅÀÌ ÀÇ·á±â±â °ËÁ¤ ¹× °ËÁõ ½ÃÀåÀ» Çü¼ºÇϰí Àִ°¡?

½Ã¹Ä·¹ÀÌ¼Ç Åø, ÀÚµ¿È­ ¹× µ¥ÀÌÅÍ ºÐ¼®ÀÇ Çõ½ÅÀÌ ÀÇ·á±â±â °ËÁ¤ ¹× °ËÁõ ½ÃÀåÀ» ÀçÆíÇϰí ÀÖ½À´Ï´Ù. ½Ã¹Ä·¹ÀÌ¼Ç ¼ÒÇÁÆ®¿þ¾î¸¦ ÅëÇØ ¿£Áö´Ï¾î´Â ¹°¸®Àû ÇÁ·ÎÅäŸÀÔÀ» Á¦ÀÛÇϱâ Àü¿¡ °¡»ó ȯ°æ¿¡¼­ µð¹ÙÀ̽ºÀÇ ¼º´ÉÀ» Å×½ºÆ®ÇÒ ¼ö ÀÖ¾î °³¹ß ÇÁ·Î¼¼½ºÀÇ ¼Óµµ¸¦ ³ôÀÌ°í ºñ¿ëÀ» Àý°¨ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÚµ¿ Å×½ºÆ® ½Ã½ºÅÛÀº ¿©·¯ Å×½ºÆ®¸¦ µ¿½Ã¿¡ ½ÇÇàÇÏ°í ºÐ¼®¿ë µ¥ÀÌÅ͸¦ ½Ç½Ã°£À¸·Î ¼öÁýÇÏ¿© È¿À²¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù. ¶ÇÇÑ, ÷´Ü µ¥ÀÌÅÍ ºÐ¼® µµ±¸´Â Á¦Á¶¾÷ü°¡ °³¹ß ÇÁ·Î¼¼½º Ãʱ⿡ ÀáÀçÀûÀÎ ¹®Á¦¸¦ ÆÄ¾ÇÇÏ¿© µð¹ÙÀ̽º ¼³°è ¹× Á¦Á¶ °øÁ¤À» ¹Ì¸® Á¶Á¤ÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº °ËÁ¤ ¹× °ËÁõ ÇÁ·Î¼¼½º¸¦ ´õ¿í öÀúÇÏ°í ½Å¼ÓÇÏ¸ç ºñ¿ë È¿À²ÀûÀ¸·Î °³¼±Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­´Â ÀÇ·á±â±â °ËÁ¤ ¹× °ËÁõÀÇ ¼ºÀåÀ» ¾î¶»°Ô Á¤ÀÇÇÒ °ÍÀΰ¡?

Á¦Ç° À¯Çü¿¡´Â Áø´Ü±â±â, Ä¡·á ±â±â, ÀÓÇöõÆ® µîÀÌ ÀÖÀ¸¸ç, Áø´Ü±â±â´Â Á¤È®¼º°ú ½Å·Ú¼º¿¡ ´ëÇÑ ¿ä±¸°¡ ³ô±â ¶§¹®¿¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ¼­ºñ½º À¯Çü¿¡´Â ÀÚü °Ë»ç ¹× ¾Æ¿ô¼Ò½Ì ¼­ºñ½º°¡ ÀÖÀ¸¸ç, ¸¹Àº ±â¾÷µéÀÌ Àü¹® Áö½ÄÀ» ¾ò±â À§ÇØ ¾Æ¿ô¼Ò½ÌÀ» ¼±ÅÃÇϰí ÀÖ½À´Ï´Ù. Áö¿ªº°·Î´Â ºÏ¹Ì°¡ °­·ÂÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©¿Í ¼±ÁøÈ­µÈ ÇコÄɾî ÀÎÇÁ¶ó¸¦ ¹ÙÅÁÀ¸·Î ½ÃÀåÀ» ÁÖµµÇϰí ÀÖÀ¸¸ç, À¯·´°ú ¾Æ½Ã¾ÆÅÂÆò¾çµµ ÀÇ·á±â±â »ê¾÷ÀÇ ¼ºÀåÀ¸·Î ÀÎÇØ ÁÖ¿ä ½ÃÀåÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù.

ÀÇ·á±â±â °ËÁ¤ ¹× °ËÁõ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

ÀÇ·á±â±â °ËÁ¤ ¹× °ËÁõ ½ÃÀåÀÇ ¼ºÀåÀº ±ÔÁ¦ ´ç±¹ÀÇ °¨½Ã °­È­, ÀÇ·á±â±âÀÇ º¹À⼺ Áõ°¡, ½Å·ÚÇÒ ¼ö ÀÖ°í ¾ÈÀüÇÑ ÀÇ·á±â±â¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. ÀÇ·á±â±âÀÇ °íµµÈ­, ƯÈ÷ µðÁöÅÐ ±â¼úÀÇ ÅëÇÕ¿¡ µû¶ó °ËÁ¤ ¹× °ËÁõ ÇÁ·Î¼¼½º´Â ¼¼°è Ç¥ÁØÀ» ÁؼöÇÒ ¼ö ÀÖµµ·Ï ÁøÈ­ÇØ¾ß ÇÕ´Ï´Ù. ±ÔÁ¦ ´ç±¹Àº ´õ¿í ¾ö°ÝÇÑ °¡À̵å¶óÀÎÀ» µµÀÔÇϰí ÀÖÀ¸¸ç, ½ÃÀå ½ÂÀÎÀ» ¹Þ±â À§Çؼ­´Â öÀúÇÑ °ËÁõ°ú °ËÁõÀÌ ÇʼöÀûÀÔ´Ï´Ù. ¶ÇÇÑ, ȯÀÚ ¾ÈÀü¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ±â±â ¸®ÄÝÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Á¦Á¶¾÷ü´Â ÀÌ·¯ÇÑ Áß¿äÇÑ ÇÁ·Î¼¼½º¿¡ ÅõÀÚÇÏ¿© ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

±â¼ú(±â°èÀû ½ÃÇè, »ý¹°ÇÐÀû ½ÃÇè, EMC/ECI, Àü±âÀû ¾ÈÀü¼º ½ÃÇè), Ä¡·á ºÐ¾ß(Á¾¾çÇÐ, Á¤Çü¿Ü°ú, È£Èí±âÇÐ, ½Å°æÇÐ, ±âŸ Ä¡·á ºÐ¾ß), ¿ëµµ(Áø´Ü, Ä¡·á, ÀÓÇöõÆ®)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

¿ì¸®´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM ¹× ¾÷°èº° SLM Äõ¸®¸¦ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Medical Device Validation and Verification Market to Reach US$1.8 Billion by 2030

The global market for Medical Device Validation and Verification estimated at US$953.1 Million in the year 2024, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 10.7% over the analysis period 2024-2030. Mechanical Testing, one of the segments analyzed in the report, is expected to record a 10.1% CAGR and reach US$668.4 Million by the end of the analysis period. Growth in the Biological segment is estimated at 11.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$246.2 Million While China is Forecast to Grow at 14.0% CAGR

The Medical Device Validation and Verification market in the U.S. is estimated at US$246.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$401.0 Million by the year 2030 trailing a CAGR of 14.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.3% and 8.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR.

Global Medical Device Validation and Verification Market - Key Trends and Drivers Summarized

Why Is Medical Device Validation and Verification Critical?

Medical device validation and verification are critical processes that ensure medical devices meet regulatory standards and perform as intended before they are released to the market. Validation confirms that the device meets the needs of users under actual conditions, while verification ensures that the product complies with design specifications. These processes are essential in the development of medical devices to prevent malfunctions, ensure patient safety, and comply with regulatory requirements from agencies such as the FDA and the European Medicines Agency (EMA). Effective validation and verification processes are key to reducing product recalls, improving patient outcomes, and maintaining the reputation of medical device companies.

What Innovations Are Shaping the Medical Device Validation and Verification Market?

Innovations in simulation tools, automation, and data analytics are reshaping the medical device validation and verification market. Simulation software allows engineers to test the performance of devices in virtual environments before physical prototypes are produced, speeding up the development process and reducing costs. Automated testing systems are also improving efficiency by running multiple tests simultaneously and collecting real-time data for analysis. Furthermore, advanced data analytics tools are helping manufacturers identify potential issues early in the development process, enabling proactive adjustments to device design or production processes. These innovations are making the validation and verification process more thorough, faster, and cost-effective.

How Do Market Segments Define the Growth of Medical Device Validation and Verification?

Product types include diagnostic equipment, therapeutic devices, and implants, with diagnostic equipment accounting for the largest market share due to the stringent requirements for accuracy and reliability. Service types include in-house testing and outsourced services, with many companies opting for outsourcing to benefit from specialized expertise. Geographically, North America leads the market, driven by the strong regulatory framework and advanced healthcare infrastructure, while Europe and Asia-Pacific are also key markets due to their growing medical device industries.

What Factors Are Driving the Growth in the Medical Device Validation and Verification Market?

The growth in the medical device validation and verification market is driven by several factors, including increasing regulatory scrutiny, the growing complexity of medical devices, and the rising demand for reliable and safe medical equipment. As medical devices become more sophisticated, particularly with the integration of digital technologies, validation and verification processes must evolve to ensure compliance with global standards. Regulatory agencies are also implementing stricter guidelines, making thorough validation and verification essential to gaining market approval. Additionally, the increasing focus on patient safety and the rise in device recalls are prompting manufacturers to invest more in these critical processes, further driving market growth.

SCOPE OF STUDY:

The report analyzes the Medical Device Validation and Verification market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Mechanical Testing, Biological, EMC / ECI, Electrical Safety Testing); Therapeutic Area (Oncology, Orthopedics, Respiratory, Neurology, Other Therapeutic Areas); Application (Diagnostics, Therapeutic, Implants)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â